Historical record - last NADAC publication: 3/17/2021

Product Information

CARVEDILOL 3.125 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0224 per EA under NDC 76385011001. Its NADAC has been published 233 times since Oct 19, 2016.

The High Outlier badge above means this manufacturer's average price in the Carvedilol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CARVEDILOL 3.125 MG TABLET

Carvedilol
$0.0224per EA
High Outlier

Strength

3.125 mg/1

NDC

76385011001

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

3/17/2021

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078384

On Market Since

10/1/2016

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 3.125 MG TABLET has been published 233 times since Oct 19, 2016, and over the history we have for it it has declined 22.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0224 per EA
All-time high$0.0291 (Mar 15, 2017)
All-time low$0.0212 (Nov 18, 2020)
Median price$0.0246
Average price$0.0250
Largest weekly change+14.9% (Jul 18, 2018)
Weeks tracked233
Tracking sinceOct 19, 2016

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-22.9%

Generic Alternatives

The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARVEDILOL 3.125 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 3.125 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0224 per EA (NDC 76385011001), effective Mar 31, 2021.

How has the price of CARVEDILOL 3.125 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 3.125 MG TABLET has declined 22.9%. It has been tracked across 233 weekly CMS publications since Oct 19, 2016.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 3.125 MG TABLET?

Since Oct 19, 2016, the NADAC for CARVEDILOL 3.125 MG TABLET has ranged from a low of $0.0212 (Nov 18, 2020) to a high of $0.0291 (Mar 15, 2017), with a median of $0.0246 per EA.

Are there cheaper alternatives to CARVEDILOL 3.125 MG TABLET?

Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CARVEDILOL 3.125 MG TABLET, is $0.0170 per EA — about 24% below CARVEDILOL 3.125 MG TABLET.

Who manufactures CARVEDILOL 3.125 MG TABLET?

CARVEDILOL 3.125 MG TABLET (NDC 76385011001) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.